Gradipore

Gradipore was an Australian biotechnology company focused on membrane-based separation technologies for life-science research and plasma processing, along with hematology diagnostics. Its core proprietary platform, Gradiflow, was a preparative electrophoresis and membrane separation technology designed to isolate and purify biological molecules with high yield and purity. The company also marketed blood clotting and thrombophilia diagnostic products, including assays related to lupus anticoagulant and Factor V Leiden testing. In 2004, Gradipore began trading as Life Therapeutics as part of a strategic shift toward plasma-derived therapeutics, while certain diagnostics operations continued under the Gradipore name for regulatory reasons. Based on the available record, "Gradipore" is best understood as a historical biotech company/brand rather than a currently operating standalone company.